Market Place
Sourcing Support
Seyltx Gains Option to Boost Cough Pipeline with 8 NeurOp Drugs
05 Jun 2025 //
BUSINESSWIRE
WAINZUA (Eplontersen) Gets EU Nod For Hereditary ATTR Amyloidosis
10 Mar 2025 //
BUSINESSWIRE
NeuroPace to Host Investor Day on January 28th in New York City
12 Dec 2024 //
GLOBENEWSWIRE
Brain Cancer Canada Awards $100K Grant for Pediatric Research
03 Dec 2024 //
GLOBENEWSWIRE
NeuroPace Completes Lennox-Gastaut Syndrome Study
03 Dec 2024 //
GLOBENEWSWIRE
NeuroPace Reports Q3 2024 Financial Results & Increases Revenue
12 Nov 2024 //
GLOBENEWSWIRE
Intellia Therapeutics Q3 2024 Results & Company Progress
07 Nov 2024 //
GLOBENEWSWIRE
Spur Therapeutics Publishes Preclinical Data for SBT101 in AMN
31 Oct 2024 //
GLOBENEWSWIRE
OKYO Pharma Doses First Patient in Neuropathic Pain Trial
23 Oct 2024 //
GLOBENEWSWIRE
NeuroPace To Report Q3 2024 Financial Results On Nov 12
22 Oct 2024 //
GLOBENEWSWIRE
NeuroPace Continues to Strengthen Management Team
16 Oct 2024 //
GLOBENEWSWIRE
Neurophet And AriBio Partner For Next-Gen Alzheimer’s Diagnosis
15 Oct 2024 //
CONTRACTPHARMA
Arialys Therapeutics Doses First Participants In ART5803 Trial
10 Oct 2024 //
BUSINESSWIRE
NeuroPace To Attend Two Upcoming Healthcare Investor Conferences
27 Aug 2024 //
GLOBENEWSWIRE
NeuroPace Reports Q2 2024 Results And Increases 2024 Revenue Guidance
13 Aug 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.